RecallRadar

FDA Drug recall D-0130-2024

PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30

On 2023-12-06 the FDA classified a Class II recall of PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30 by Golden State Medical Supply, citing failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0130-2024
ClassificationClass II
Statusterminated
Initiated2023-11-10
Published2023-12-06
Last updated2026-09-13 11:52 UTC
CompanyGolden State Medical Supply
DistributionUS

Product

PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDC 60429-737-90; c)1000-count bottle, NDC 60429-737-10; Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario, Canada, M9L 1T9, Packaged by GSMS, Incorporated, Camarillo, CA 93012.

Reason

Failed Impurities/Degradation Specifications-Manufacturer Apotex Inc. recalling lots due to Out of specification results for the excipient Amadori Glucose adduct of Paroxetine

Identifiers

ndc60429-734-30
ndc60429-734-90
ndc60429-734-10
ndc60429-735-30
ndc60429-735-90
ndc60429-735-10
ndc60429-736-30
ndc60429-736-90
ndc60429-736-10
ndc60429-737-30
ndc60429-737-90
ndc60429-737-10
code_infoLot # a) GS036488, GS037091, GS037701, Exp. 08/31/2024; b) GS037090, GS037702, Exp. 08/31/2024; c) GS036677, GS037117, GS037699, Exp. 08/31/2024

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0130-2024%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.